Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 7Gastrointestinal 5Other hematologic neoplasm 3Dermatologic 3Lymphoid 2Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Genitourinary 1CNS 1Breast 1

Conditions

Early Stage Non-Small Cell Lung Cancer 1

Interventions

Carboplatin 1167Cisplatin 889Pemetrexed 845pembrolizumab 622Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 124Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vancomycin × Thoracic × Clear all
NCT03546829 2026-01-14

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Recruiting
10 enrolled
Thoracic

Early Stage Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡